NIH-funded research R21 grant

Creating genetically modified Xiphophorus fish to study cancer and other diseases

Official title: Development of genome-modified Xiphophorus

Funded at Texas State University · NIH-10689339 · Data updated 2026-11-12

This study is looking at specially modified fish to help us learn more about cancer and other diseases, which could eventually lead to better treatments or ways to prevent conditions like skin cancer for patients.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas State University
NIH-funded
Lab location1 site (San Marcos, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2025
Funding year2023
Award (this year)$188,125
NIH project number5R21OD031910-02
Project IDNIH-10689339 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals at risk for skin cancer or those interested in advancements in cancer treatment.

Less likely to help

Patients with conditions unrelated to cancer or those not at risk for skin-related diseases may not receive direct benefits from this research.

What this research studies

This research focuses on developing genetically modified Xiphophorus fish, which are valuable models for understanding cancer and other diseases. By utilizing advanced genomic techniques, the project aims to identify and validate genes that influence tumor progression and other health conditions. Patients may benefit from insights gained through this research, as it could lead to new treatments or preventive strategies for diseases like skin cancer. The study leverages the unique biological characteristics of Xiphophorus to explore complex disease mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in understanding and treating various cancers and related health issues.

How similar studies have gone: Previous research using Xiphophorus as a model organism has shown promise in understanding cancer biology and other diseases, indicating a strong potential for success in this approach.

Where this research is happening

  • Texas State University
    San Marcos, United States
    Active

Researchers

  • Principal investigator: Schartl, Manfred — Texas State University
  • Study coordinator: Schartl, Manfred

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.